Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2025Minerva Endocrinology

Genomic mapping of diabetic kidney disease biomarkers and identification of potential inhibitors through virtual screening

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYi LiuYWYu Wang

Discussion

Loading...

Member takes

Overview

Genomic analysis reveals new biomarkers and identifies potential inhibitors in diabetic kidney disease, suggesting novel therapeutic options.

Key Points

  • Identified biomarkers offer new diagnostic pathways for diabetic kidney disease, emphasizing molecular relevance.
  • Genomic analysis involved comprehensive datasets including microarray and RNA-seq approaches from established databases.
  • Virtual screening led to the discovery of inhibitors demonstrating significant binding affinity, pivotal for therapeutic development.
  • Findings highlight the need for experimental validation to enhance precision diagnosis and treatment strategies.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68f9f86eb2c35e10cc4e3c57https://doi.org/10.23736/s2724-6507.25.04399-4
View Full Paper
Ask AI
Bookmark
Share